EI
NMRD

Ellevest Inc’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Ellevest Inc’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30
Closed – – 1628
2021
Q2 		$0 Buy
30
+4
+15% +$38 ﹤0.01% 1446
2021
Q1 		$0 Buy
+26
New +$172 ﹤0.01% 1381

Other funds holding NMRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ellevest Inc's NMRD Position: Q3 2021 in Review

Ellevest Inc sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q3 2021, closing a stake of 30 shares.

Ellevest Inc first reported a position in NMRD in Q1 2021 and held it in 2 quarters. The position peaked at $0 in Q2 2021. 17 funds tracked by Wall St. Rank hold NMRD as of Q3 2021.

  • Ellevest Inc reported no remaining Nemaura Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Ellevest Inc sold 30 Nemaura Medical, Inc. Common Stock shares in Q3 2021.
  • Ellevest Inc first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Ellevest Inc's Nemaura Medical, Inc. Common Stock position peaked at $0 in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.